{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:40:00Z","timestamp":1768315200111,"version":"3.49.0"},"reference-count":200,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jinf.2010.06.002","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T04:31:06Z","timestamp":1276489866000},"page":"101-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The HIV-1\/HAART associated metabolic syndrome \u2013 Novel adipokines, molecular associations and therapeutic implications"],"prefix":"10.1016","volume":"61","author":[{"given":"S.","family":"Tsiodras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Perelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2010.06.002_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib2","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJM199810293391806","article-title":"Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor","volume":"339","author":"Carr","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib4","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study","volume":"160","author":"Tsiodras","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib5","first-page":"225","article-title":"Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART)","volume":"25","author":"Vigouroux","year":"1999","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ajcn\/69.6.1162","article-title":"Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging","volume":"69","author":"Engelson","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jinf.2010.06.002_bib7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.physbeh.2004.09.016","article-title":"The new concept of adipose tissue function","volume":"83","author":"Hauner","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jinf.2010.06.002_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1079\/BJN20041213","article-title":"Adipokines: inflammation and the pleiotropic role of white adipose tissue","volume":"92","author":"Trayhurn","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jinf.2010.06.002_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(05)64011-1","article-title":"Benign symmetric lipomatosis associated with protease inhibitors","volume":"350","author":"Hengel","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2010.06.002_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QAI.0b013e31804a85b0","article-title":"Prevalence of and risk factors for pubic lipoma development in HIV-infected persons","volume":"45","author":"Guaraldi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib13","first-page":"23","article-title":"A case-control study of gynecomastia in HIV-1-infected patients receiving HAART","volume":"14","author":"Rahim","year":"2004","journal-title":"AIDS Read"},{"key":"10.1016\/j.jinf.2010.06.002_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.qai.0000229996.75116.da","article-title":"Fat distribution in women with HIV infection","volume":"42","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.metabol.2006.02.024","article-title":"Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy","volume":"55","author":"Estrada","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2010.06.002_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib20","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/498022","article-title":"CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study","volume":"41","author":"McDermott","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib22","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200110190-00003","article-title":"Clinical perspectives on HIV-associated lipodystrophy syndrome: an update","volume":"15","author":"Shevitz","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/380790","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL Study","volume":"38","author":"McComsey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib25","unstructured":"Murphy R, Katlama C, Weverling G-J, Hoff F, Roubenoff R, Berzins B, et\u00a0al. Fat redistribution and metabolic study (FRAMS) in patients receiving a nucleoside reverse transcriptase inhibitor, or protease inhibitor-based regimen over 4 years: FRAMS II substudy of the Atlantic Study. In: 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, California; 2004 February 8\u201311."},{"key":"10.1016\/j.jinf.2010.06.002_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1293.2004.00178.x","article-title":"Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors","volume":"5","author":"Reiss","year":"2004","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-200207010-00002","article-title":"Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat","volume":"30","author":"Cherry","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib28","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","article-title":"Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy","volume":"15","author":"Shikuma","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.qai.0000187443.30838.3e","article-title":"Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens","volume":"40","author":"Jones","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling","volume":"289","author":"Ross","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jinf.2010.06.002_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/498505","article-title":"Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients","volume":"42","author":"Jemsek","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib32","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/oby.2006.114","article-title":"HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism","volume":"14","author":"Kim","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.jinf.2010.06.002_bib33","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/QAD.0b013e3283021a4f","article-title":"Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes","volume":"22","author":"Jones","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2010.06.002_bib35","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/01.aids.0000242815.80462.5a","article-title":"Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs","volume":"20","author":"Pacenti","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib36","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI119870","article-title":"Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation","volume":"100","author":"Adams","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2010.06.002_bib37","first-page":"1932","article-title":"Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women","volume":"84","author":"Hadigan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib38","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042560-199903010-00003","article-title":"Studies of body composition and fat distribution in HIV-infected and control subjects","volume":"20","author":"Kotler","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jinf.2010.06.002_bib40","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00002030-200211080-00011","article-title":"Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy","volume":"16","author":"Sutinen","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/507333","article-title":"Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy","volume":"43","author":"Wohl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib42","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00125-004-1508-2","article-title":"In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing\u2019s syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue","volume":"47","author":"Sutinen","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2010.06.002_bib43","first-page":"31","article-title":"Complications of HIV disease and antiretroviral therapy","volume":"12","author":"Currier","year":"2004","journal-title":"Top HIV Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"86","author":"Grunfeld","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib45","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2010.06.002_bib47","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia","volume":"7","author":"Liang","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/joe.0.1720155","article-title":"The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes","volume":"172","author":"Ranganathan","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jinf.2010.06.002_bib50","doi-asserted-by":"crossref","first-page":"E490","DOI":"10.1152\/ajpendo.00118.2003","article-title":"Alterations in lipid kinetics in men with HIV-dyslipidemia","volume":"285","author":"Reeds","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","article-title":"Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study","volume":"363","author":"van Leth","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2010.06.002_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00126334-200107010-00005","article-title":"Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy","volume":"27","author":"Duong","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib54","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jinf.2010.06.002_bib56","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib57","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0115426505020006668","article-title":"Alterations in lipid profiles in HIV-infected patients treated with protease inhibitor therapy are not influenced by diet","volume":"20","author":"Wanke","year":"2005","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jinf.2010.06.002_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00002030-200202150-00006","article-title":"CD36 deficiency induced by antiretroviral therapy","volume":"16","author":"Serghides","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib60","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00126334-200405010-00017","article-title":"HIV protease inhibitors increase adiponectin levels in HIV-negative men","volume":"36","author":"Lee","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib61","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2010.06.002_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00126334-200305010-00006","article-title":"Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors","volume":"33","author":"Beatty","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib63","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/meta.2002.29999","article-title":"Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution","volume":"51","author":"Meininger","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2010.06.002_bib64","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0026-0495(03)00201-4","article-title":"Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function","volume":"52","author":"Andersen","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2010.06.002_bib65","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1152\/ajpendo.00009.2004","article-title":"Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells","volume":"287","author":"Haugaard","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib66","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1128\/JVI.76.19.9724-9734.2002","article-title":"Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300\/CBP coactivators","volume":"76","author":"Kino","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2010.06.002_bib67","unstructured":"Shrivastav S, Kino T, Chrousos GP, Kopp JB. HIV-1 Vpr binds and inhibits PPAR-gamma: implications for HIV-associated insulin resistance and lipodystrophy. In: International Meeting of the Institute of Human Virology; Baltimore; 2000."},{"key":"10.1016\/j.jinf.2010.06.002_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/diabetes.54.1.23","volume":"54","author":"Kino","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib69","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1073\/pnas.93.16.8374","article-title":"The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors","volume":"93","author":"Baumann","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2010.06.002_bib70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2010.06.002_bib71","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/s-2007-979873","article-title":"Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob\/ob mice","volume":"28","author":"Hwa","year":"1996","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jinf.2010.06.002_bib72","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2010.06.002_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0026-0495(97)90258-4","article-title":"Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity","volume":"46","author":"Yarasheski","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2010.06.002_bib74","first-page":"4342","article-title":"Serum leptin levels in the acquired immunodeficiency syndrome","volume":"81","author":"Grunfeld","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib75","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2362.2006.01699.x","article-title":"Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects","volume":"36","author":"Schindler","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jinf.2010.06.002_bib76","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib77","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1074\/jbc.M408687200","article-title":"Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines","volume":"280","author":"Vernochet","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2010.06.002_bib78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350300800102","article-title":"Adipocyte-derived hormone levels in HIV lipodystrophy","volume":"8","author":"Kosmiski","year":"2003","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib79","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib80","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/01.aids.0000189852.21441.2a","article-title":"Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy","volume":"19","author":"Wunder","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/135965350501000113","article-title":"Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy","volume":"10","author":"Kovacic","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib82","doi-asserted-by":"crossref","first-page":"27758","DOI":"10.1074\/jbc.272.44.27758","article-title":"Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action","volume":"272","author":"Rossetti","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2010.06.002_bib83","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.biocel.2005.11.008","article-title":"Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes","volume":"38","author":"Zhao","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jinf.2010.06.002_bib84","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1210\/endo.140.8.6890","article-title":"Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue","volume":"140","author":"Rouru","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jinf.2010.06.002_bib85","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI119834","article-title":"Direct effects of leptin on brown and white adipose tissue","volume":"100","author":"Siegrist-Kaiser","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2010.06.002_bib86","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/38717","article-title":"Acute stimulation of glucose metabolism in mice by leptin treatment","volume":"389","author":"Kamohara","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2010.06.002_bib87","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jinf.2010.06.002_bib88","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.52.7.1655","article-title":"Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors","volume":"52","author":"Iwaki","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib89","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","article-title":"PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein","volume":"50","author":"Maeda","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib90","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib91","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2337\/diabetes.51.6.1884","article-title":"Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans","volume":"51","author":"Stefan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib92","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib93","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib94","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2010.06.002_bib95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2006.11.058","article-title":"High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes","volume":"352","author":"Neumeier","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jinf.2010.06.002_bib96","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/ATVBAHA.108.163634","article-title":"Adiponectin protects against angiotensin II or tumor necrosis factor alpha-induced endothelial cell monolayer hyperpermeability: role of cAMP\/PKA signaling","volume":"28","author":"Xu","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jinf.2010.06.002_bib97","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/01.RES.0000196745.09234.36","article-title":"Endothelial cell IL-8, a new target for adiponectin: implications in vascular protection","volume":"97","author":"Touyz","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jinf.2010.06.002_bib98","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2008.06.009","article-title":"Reversal of oxidative stress in endothelial cells by controlled release of adiponectin","volume":"130","author":"Mossalam","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.jinf.2010.06.002_bib99","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.ATV.0000194076.84568.81","article-title":"Adiponectin acts as an endogenous antithrombotic factor","volume":"26","author":"Kato","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jinf.2010.06.002_bib100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3132\/dvdr.2008.017","article-title":"Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins","volume":"5","author":"Plant","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jinf.2010.06.002_bib101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.qai.0000159323.59250.83","article-title":"Increased cardiovascular disease risk indices in HIV-infected women","volume":"39","author":"Dolan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib102","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00125-005-0085-3","article-title":"In treatment-naive and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100","volume":"49","author":"Das","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2010.06.002_bib103","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib104","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.metabol.2004.08.022","article-title":"Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy","volume":"54","author":"Chaparro","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2010.06.002_bib105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/135965350501000202","article-title":"Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors","volume":"10","author":"Jones","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-143-5-200509060-00009","article-title":"Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial","volume":"143","author":"van Wijk","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib107","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1055\/s-2005-870526","article-title":"The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes","volume":"37","author":"Grigem","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jinf.2010.06.002_bib108","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib109","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1468-1293.2006.00372.x","article-title":"Regulation of adiponectin in adipocytes upon exposure to HIV-1","volume":"7","author":"Sankale","year":"2006","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1203\/01.pdr.0000228335.64894.26","article-title":"Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome","volume":"60","author":"Verkauskiene","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jinf.2010.06.002_bib111","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1515\/JPEM.2007.20.1.65","article-title":"Hypoadiponectinemia, dyslipidemia, and impaired growth in children with HIV-associated facial lipoatrophy","volume":"20","author":"Kim","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib112","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2005.09.001","article-title":"Age and sex modulate metabolic and cardiovascular risk markers of patients after 1 year of highly active antiretroviral therapy (HAART)","volume":"187","author":"Leitner","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jinf.2010.06.002_bib113","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/dc07-2024","article-title":"Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries","volume":"31","author":"Marso","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jinf.2010.06.002_bib114","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2143\/AC.63.2.2029522","article-title":"The association between plasma adiponectin level and hypertension","volume":"63","author":"Shankar","year":"2008","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jinf.2010.06.002_bib115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2010.06.002_bib116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0014-5793(02)03108-3","article-title":"Resistin expression and regulation in mouse pituitary","volume":"526","author":"Morash","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jinf.2010.06.002_bib117","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(03)00708-7","article-title":"Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner","volume":"548","author":"Nogueiras","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jinf.2010.06.002_bib118","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.metabol.2004.10.015","article-title":"Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters","volume":"54","author":"Chen","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2010.06.002_bib119","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance","volume":"149","author":"Silha","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jinf.2010.06.002_bib121","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00125-005-1932-y","article-title":"Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans","volume":"48","author":"Utzschneider","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2010.06.002_bib122","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-1119(02)01213-1","article-title":"The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications","volume":"305","author":"Ghosh","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.jinf.2010.06.002_bib123","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1210\/jc.2005-0742","article-title":"Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome","volume":"90","author":"Barb","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib124","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/QAD.0b013e32830a9886","article-title":"Genetic analysis implicates resistin in HIV lipodystrophy","volume":"22","author":"Ranade","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib125","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1210\/jc.2005-0287","article-title":"Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone","volume":"90","author":"Kamin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib126","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2010.06.002_bib127","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI29027","article-title":"Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony","volume":"116","author":"Herman","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2010.06.002_bib128","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.clpt.6100047","article-title":"Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients","volume":"81","author":"Haider","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib129","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2174\/092986708785133004","article-title":"Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions","volume":"15","author":"Adeghate","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jinf.2010.06.002_bib130","first-page":"1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor","volume":"14","author":"Samal","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jinf.2010.06.002_bib131","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jinf.2010.06.002_bib132","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","article-title":"Plasma visfatin concentrations and fat depot-specific mRNA expression in humans","volume":"54","author":"Berndt","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib133","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2005-2248","article-title":"Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding","volume":"91","author":"Haider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib134","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI19930","article-title":"Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis","volume":"113","author":"Jia","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2010.06.002_bib135","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1067\/mob.2002.126295","article-title":"Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes","volume":"187","author":"Ognjanovic","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jinf.2010.06.002_bib136","first-page":"205","article-title":"Searching for candidate genes in acute lung injury: SNPs, Chips and PBEF","volume":"116","author":"Garcia","year":"2005","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.jinf.2010.06.002_bib137","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1164\/rccm.200404-563OC","article-title":"Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury","volume":"171","author":"Ye","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib138","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","article-title":"Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib139","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbrc.2005.11.039","article-title":"Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes","volume":"339","author":"Kloting","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jinf.2010.06.002_bib140","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2006-0361","article-title":"Reduced plasma visfatin\/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans","volume":"91","author":"Pagano","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib141","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.jinf.2010.06.002_bib142","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-4889(99)00114-7","article-title":"Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum","volume":"1452","author":"Habata","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jinf.2010.06.002_bib143","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"Medhurst","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.jinf.2010.06.002_bib144","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jinf.2010.06.002_bib145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.regpep.2005.05.003","article-title":"Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding","volume":"130","author":"Heinonen","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.jinf.2010.06.002_bib146","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.0000091235.94914.75","article-title":"Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction","volume":"108","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2010.06.002_bib147","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-291X(03)01424-4","article-title":"Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure","volume":"308","author":"Foldes","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jinf.2010.06.002_bib148","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/viro.2000.0557","article-title":"Expression and coreceptor function of APJ for primate immunodeficiency viruses","volume":"276","author":"Puffer","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.jinf.2010.06.002_bib149","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-5793(00)01487-3","article-title":"Apelin peptides block the entry of human immunodeficiency virus (HIV)","volume":"473","author":"Zou","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jinf.2010.06.002_bib150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.regpep.2005.08.003","article-title":"Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes","volume":"132","author":"Wei","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.jinf.2010.06.002_bib151","first-page":"337","article-title":"Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia","volume":"16","author":"Esposito","year":"2002","journal-title":"In Vivo"},{"key":"10.1016\/j.jinf.2010.06.002_bib152","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0083-6729(05)70010-8","article-title":"Novel roles for acylation stimulating protein\/C3adesArg: a review of recent in vitro and in vivo evidence","volume":"70","author":"Maslowska","year":"2005","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jinf.2010.06.002_bib153","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(02)00686-7","article-title":"Critical review of acylation-stimulating protein physiology in humans and rodents","volume":"1609","author":"Cianflone","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2010.06.002_bib154","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1086\/375891","article-title":"Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy","volume":"37","author":"Kotler","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/135965350601100601","article-title":"Protease inhibitor effects on triglyceride synthesis and adipokine secretion in human omental and subcutaneous adipose tissue","volume":"11","author":"Cianflone","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib156","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","article-title":"Adipokines and insulin resistance","volume":"14","author":"Rabe","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib157","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/db06-1506","article-title":"Omentin plasma levels and gene expression are decreased in obesity","volume":"56","author":"de Souza Batista","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib158","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2840-6-3","article-title":"Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases","volume":"6","author":"Schaffler","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jinf.2010.06.002_bib159","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/db07-0990","article-title":"Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib160","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1464-5491.2008.02568.x","article-title":"Decreased plasma omentin-1 levels in Type 1 diabetes mellitus","volume":"25","author":"Tan","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib161","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2010.06.002_bib162","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.metabol.2008.02.019","article-title":"Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue","volume":"57","author":"Fain","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.jinf.2010.06.002_bib163","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2010.06.002_bib164","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cytogfr.2007.04.007","article-title":"The emerging role of adipokines as mediators of inflammation and immune responses","volume":"18","author":"Lago","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jinf.2010.06.002_bib165","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1073\/pnas.0505429103","article-title":"Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans","volume":"103","author":"Chan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2010.06.002_bib166","first-page":"239","article-title":"The emerging role of leptin in humans","volume":"3","author":"Kelesidis","year":"2006","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.jinf.2010.06.002_bib167","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.4049\/jimmunol.174.6.3137","article-title":"Leptin in immunology","volume":"174","author":"Matarese","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2010.06.002_bib168","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0704903","article-title":"Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1","volume":"137","author":"Raso","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jinf.2010.06.002_bib169","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1096\/fsb2fasebj.12.1.57","article-title":"Leptin regulates proinflammatory immune responses","volume":"12","author":"Loffreda","year":"1998","journal-title":"Faseb J"},{"key":"10.1016\/j.jinf.2010.06.002_bib170","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/1071576031000097526","article-title":"Leptin regulates functional capacities of polymorphonuclear neutrophils","volume":"37","author":"Caldefie-Chezet","year":"2003","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jinf.2010.06.002_bib171","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1189\/jlb.69.3.414","article-title":"Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action?","volume":"69","author":"Caldefie-Chezet","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jinf.2010.06.002_bib172","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.4049\/jimmunol.174.12.8090","article-title":"Apoptotic pathways are inhibited by leptin receptor activation in neutrophils","volume":"174","author":"Bruno","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2010.06.002_bib173","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jaci.2005.09.003","article-title":"Leptin is an eosinophil survival factor","volume":"116","author":"Conus","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jinf.2010.06.002_bib174","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/cimm.1999.1594","article-title":"Human leptin enhances activation and proliferation of human circulating T lymphocytes","volume":"199","author":"Martin-Romero","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jinf.2010.06.002_bib175","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.4049\/jimmunol.176.12.7745","article-title":"Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice","volume":"176","author":"Papathanassoglou","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2010.06.002_bib176","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.4049\/jimmunol.174.11.6820","article-title":"Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming","volume":"174","author":"Mattioli","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2010.06.002_bib177","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4049\/jimmunol.168.2.875","article-title":"Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis","volume":"168","author":"Busso","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2010.06.002_bib178","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","volume":"84","author":"Ozata","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib179","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.CIR.103.8.1057","article-title":"Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages","volume":"103","author":"Ouchi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2010.06.002_bib180","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1210\/jc.2002-021583","article-title":"Novel interactions of adiponectin with the endocrine system and inflammatory parameters","volume":"88","author":"Fernandez-Real","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib181","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1016\/j.febslet.2005.11.019","article-title":"Adiponectin inhibits toll-like receptor family-induced signaling","volume":"579","author":"Yamaguchi","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jinf.2010.06.002_bib182","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbrc.2005.07.197","article-title":"Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli","volume":"335","author":"Tsatsanis","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jinf.2010.06.002_bib183","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbrc.2004.02.130","article-title":"Adiponectin differentially regulates cytokines in porcine macrophages","volume":"316","author":"Wulster-Radcliffe","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jinf.2010.06.002_bib184","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/eurheartj\/ehi340","article-title":"Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers","volume":"26","author":"Rothenbacher","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jinf.2010.06.002_bib185","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1210\/jc.2009-0340","article-title":"Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?","volume":"94","author":"Mantzoros","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib186","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00126334-200308150-00003","article-title":"Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice","volume":"33","author":"Riddle","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib187","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/en.2003-1140","article-title":"Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice","volume":"145","author":"Xu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jinf.2010.06.002_bib188","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/jc.2005-1545","article-title":"Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib189","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with HIV-associated lipoatrophy and hypoleptinemia","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jinf.2010.06.002_bib190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EJE-08-0597","article-title":"r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans","volume":"160","author":"Brennan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jinf.2010.06.002_bib191","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2010.06.002_bib192","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/427697","article-title":"Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2\u00a0\u00d7\u00a02 factorial, randomized, double-blinded, placebo-controlled trial","volume":"40","author":"Gavrila","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.06.002_bib193","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00126334-200210010-00006","article-title":"Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study","volume":"31","author":"Gelato","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2010.06.002_bib194","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2010.06.002_bib195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART-associated lipodystrophy\u2013a randomized double-blind placebo-controlled study","volume":"8","author":"Sutinen","year":"2003","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jinf.2010.06.002_bib196","first-page":"99","article-title":"Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART","volume":"14","author":"Tomazic","year":"2005","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.jinf.2010.06.002_bib197","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAD.0b013e328011220e","article-title":"Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist\/hip ratio","volume":"21","author":"Mulligan","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2010.06.002_bib198","doi-asserted-by":"crossref","first-page":"373524","DOI":"10.1155\/2009\/373524","article-title":"The Effects of thiazolidinediones on metabolic complications and lipodystrophy in HIV-infected patients","volume":"2009","author":"Sutinen","year":"2009","journal-title":"PPAR Res"},{"key":"10.1016\/j.jinf.2010.06.002_bib199","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s15010-006-5022-y","article-title":"Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome","volume":"34","author":"Feldt","year":"2006","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2010.06.002_bib200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/135965350601100610","article-title":"HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1\/HAART-associated lipodystrophy","volume":"11","author":"Giralt","year":"2006","journal-title":"Antivir Ther"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310001672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310001672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:13:35Z","timestamp":1759007615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445310001672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":200,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0163445310001672"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2010.06.002","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The HIV-1\/HAART associated metabolic syndrome \u2013 Novel adipokines, molecular associations and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2010.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}